BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
2994 | 409.80 | 410.00 | 5 |
70 | 408.50 | 411.60 | 42 |
500 | 407.00 | 411.95 | 200 |
200 | 406.15 | 412.00 | 1 |
300 | 405.10 | 412.95 | 300 |
0 | Total | Total | 0 |
As on 28 Mar, 2023 | 04:01
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
2994 | 409.80 | 410.00 | 5 |
70 | 408.50 | 411.60 | 42 |
500 | 407.00 | 411.95 | 200 |
200 | 406.15 | 412.00 | 1 |
300 | 405.10 | 412.95 | 300 |
0 | Total | Total | 0 |
Stock with medium financial performance with average price momentum and val
Open | 435.00 |
Previous Close | 448.00 |
Volume | 1,887,801.00 |
Value (Lacs) | 7,629.55 |
VWAP | 417.20 |
Beta |
High | 441.80 |
Low | 396.50 |
UC Limit | 537.60 |
LC Limit | 358.40 |
52 Week High | 601.00 |
52 Week Low | 295.00 |
TTM EPS See historical trend | 7.92 (-30.96% YoY) |
TTM PE See historical trend | 51.03 (High PE) |
P/B See historical trend | 8.78 (Low P/B) |
Face Value | 1.00 |
Mkt Cap (Rs. Cr.) | 4,125 |
Dividend Yield | 0.25 |
20D Avg Volume | 394,287 |
20D Avg Delivery(%) | 12.72 |
Sector PE | 64.23 |
Book Value Per Share | 46.02 |
*Delayed by 20 seconds.
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
Vijaya Diagnost Standalone December 2022 Net Sales at Rs 110.97 crore, up 2.46% Y-o-Y Feb 14 2023 10:02 AM
Market breaks crucial levels in the week, but these smallcaps gain 10-28% Jan 07 2023 11:01 AM
Vijaya Diagnostics: Price stability adds to constructive take Dec 05 2022 10:12 AM
Vijaya Diagnost Standalone September 2022 Net Sales at Rs 118.26 crore, up 8.01% Y-o-Y Nov 15 2022 12:11 PM
Qty 2767033 | Price 425.75 | % Traded 2.71 |
Qty 1960267 | Price 425.75 | % Traded 1.92 |
Qty 1243005 | Price 425.75 | % Traded 1.22 |
Qty 894610 | Price 425.75 | % Traded 0.88 |
Qty 200000 | Price 425.75 | % Traded 0.20 |
Qty 197110 | Price 425.75 | % Traded 0.19 |
Qty 180000 | Price 425.75 | % Traded 0.18 |
Qty 75590 | Price 425.75 | % Traded 0.07 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 1162725 | Price 400.05 | % Traded 1.14 |
Qty 1451778 | Price 400.08 | % Traded 1.42 |
Qty 1700000 | Price 350 | % Traded 1.67 |
Qty 1952200 | Price 350.19 | % Traded 1.91 |
Qty 1850800 | Price 445 | % Traded 1.81 |
Qty 2532270 | Price 445 | % Traded 2.48 |
Qty 2767033 | Price 425.75 | % Traded 2.71 |
Qty 2035857 | Price 425.75 | % Traded 1.99 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Qty 31000 | Price 329.91 | % Traded 0.03 | Post Tnx Hold. 33.05% |
Qty 3000 | Price 329.77 | % Traded 0.00 | Post Tnx Hold. 33.02% |
Qty 28070 | Price 328.82 | % Traded 0.03 | Post Tnx Hold. 32.98% |
Qty 30000 | Price 327.02 | % Traded 0.03 | Post Tnx Hold. 33.02% |
Qty 9000 | Price 329.86 | % Traded 0.01 | Post Tnx Hold. 32.99% |
Qty 63930 | Price 328.81 | % Traded 0.06 | Post Tnx Hold. 32.95% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
Qty 1560056 | Price 0 | % Traded 1.52 | Post Tnx Hold. 5.89% |
Qty 2182717 | Price 0 | % Traded 0.13 | Post Tnx Hold. 4.62% |
Qty 4814 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 2577353 | Price 0 | % Traded 2.53 | Post Tnx Hold. 6.75% |
Qty 227309 | Price 0 | % Traded 0.22 | Post Tnx Hold. 0% |
Qty 4140872 | Price 0 | % Traded 4.06 | Post Tnx Hold. 9.06% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Vijaya Diagnost | 404.15 | -9.79 | 4,125.21 | 51.68 | 8.78 | 23.00 | -7.35 | 108 | 450 | 0.00 |
Apollo Hospital | 4,333.60 | 0.36 | 62,310.52 | 81.49 | 10.56 | 18.77 | -6.98 | 1,101 | 14,662 | 0.47 |
Max Healthcare | 449.95 | -2.06 | 43,686.67 | 44.73 | 6.94 | 9.63 | 32.22 | 605 | 3,931 | 0.12 |
Fortis Health | 259.15 | 1.57 | 19,564.74 | 37.34 | 2.79 | 8.98 | -4.36 | 765 | 5,717 | 0.16 |
Narayana Hruda | 763.90 | 2.63 | 15,611.12 | 31.09 | 10.48 | 22.96 | 5.60 | 350 | 3,701 | 0.37 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>